Elevation of circulating intestinal fatty acid binding protein in a luminal contents-initiated model of NEC.
Necrotizing enterocolitis (NEC) continues to produce significant morbidity and mortality, due in part to the difficulty in detecting its initial manifestations at a stage when compromised intestine may potentially be salvaged. We have previously reported our findings that intestinal fatty acid binding protein (I-FABP) is a sensitive biochemical marker for early intestinal mucosal injury due to mesenteric ischemia. In this study we evaluated the potential of serum I-FABP as a marker for incipient NEC in a nonischemic model of NEC in the rat. Intraluminal instillation of a solution of casein (10 mg/mL) and calcium gluconate (50 mg/mL) in saline acidified to pH 4.0 with propionic acid resulted in a rapid and prolonged increase in serum I-FABP from a baseline of < or = 4.0 ng/mL to 171 +/- 40 ng/mL. Instillation of the same electrolyte solution with either casein or propionic acid alone resulted in a less dramatic elevation of serum I-FABP to 19 +/- 4 ng/mL and 76 +/- 30 ng/mL, respectively. In both cases baseline values of < or = 4.0 ng/mL were reached within 60 minutes. In control animals, which received saline alone, serum I-FABP was undetectable throughout the experiment. Simultaneously, we found that serum hexosaminidase, a putative biochemical marker for intestinal ischemia and NEC, was unchanged in all groups. Light microscopy of the intestinal specimens obtained three hours after instillation of casein and organic acid demonstrated superficial villus necrosis and villus blunting, but no areas of transmural necrosis.(ABSTRACT TRUNCATED AT 250 WORDS)
Gollin
G
G
Department of Surgery, Yale University School of Medicine, New Haven, CT 06510.
Marks
W H
WH
D000818:Animals; D015415:Biomarkers / Q000097:blood; D002125:Calcium Gluconate; D002352:Carrier Proteins / Q000097:blood*; D002364:Caseins; D004761:Enterocolitis, Pseudomembranous / Q000097:blood* / Q000473:pathology; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D005227:Fatty Acids / Q000097:blood*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008954:Models, Biological; D009363:Neoplasm Proteins; D009419:Nerve Tissue Proteins; D051381:Rats; D011917:Rats, Inbred Lew; D025521:Tumor Suppressor Proteins
D015415:Biomarkers; D002352:Carrier Proteins; D002364:Caseins; C107608:FABP7 protein, human; C490174:Fabp7 protein, rat; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D005227:Fatty Acids; D009363:Neoplasm Proteins; D009419:Nerve Tissue Proteins; D025521:Tumor Suppressor Proteins; D002125:Calcium Gluconate